Skip to main content

Centene Corporation stock price and financials

  • CNC · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$71.27+1.42%Close 13 Nov 2026
Market value
$37.04B
P/E
25.37
EV / EBITDA
12.23
Beta · 1 year
0.48
Return · 1 year
+96.9%
52-week range$31.63 — $78.08

Share price close 16 Nov 2026

+5.6%1 monthHigh $76.01Low $66.53
$65$67.5$70$72.5$75$77.5Q3 FY2026 report filed 27 Oct 202623 Oct29 Oct4 Nov10 Nov16 Nov
+27.8%6 monthsHigh $76.01Low $57.21
$55$60$65$70$75$80Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 27 Oct 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+80.9%year to dateHigh $76.01Low $31.80
$20$40$60$80Q4 FY2025 report filed 17 Feb 2026Q1 FY2026 report filed 28 Apr 2026Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 27 Oct 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+105%1 yearHigh $76.01Low $31.80
$20$40$60$80Q4 FY2025 report filed 17 Feb 2026Q1 FY2026 report filed 28 Apr 2026Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 27 Oct 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+1.7%3 yearsHigh $80.41Low $25.21
$20$40$60$80$100Q4 FY2023 report filed 20 Feb 2024Q1 FY2024 report filed 26 Apr 2024Q2 FY2024 report filed 26 Jul 2024Q3 FY2024 report filed 25 Oct 2024Q4 FY2024 report filed 18 Feb 2025Q1 FY2025 report filed 25 Apr 2025Q2 FY2025 report filed 25 Jul 2025Q3 FY2025 report filed 29 Oct 2025Q4 FY2025 report filed 17 Feb 2026Q1 FY2026 report filed 28 Apr 2026Q2 FY2026 report filed 28 Jul 2026Q3 FY2026 report filed 27 Oct 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+162%10 yearsHigh $96.90Low $25.21
$20$40$60$80$100Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Centene Corporation reported revenue of $194.8 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 19.4% from fiscal 2024. Net income was −$6.67 billion and diluted earnings per share −$13.53.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 30 Sep 2026), revenue was $50.6 billion, up 1.9% from a year earlier.

Figures from Centene Corporation's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 27 Oct 2026.

Against Health Care

Growth
Top quarter
Revenue +11.9% a year over five years · 7th of 37
Profitability
Bottom quarter
Return on invested capital -0.0%, five-year average · 36th of 38
Balance sheet
Top 10%
More cash than debt · 4th of 38
Valuation
Below the median
P/E 25.4 · 12th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2025
$194.8B+19.4%
Net income
−$6.67B−302%
Diluted EPS
−$13.53−314%
Gross margin
7.3%−3.2 pts
Free cash flow
$4.32B
Net cash
$2.16B

Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2016–2025

  • Revenue
  • Net income
−$50B$0$50B$100B$150B$200BRevenue, FY16: $40.61BNet income, FY16: $562MFY16Revenue, FY17: $48.38BNet income, FY17: $828MFY17Revenue, FY18: $60.12BNet income, FY18: $900MFY18Revenue, FY19: $74.64BNet income, FY19: $1.32BFY19Revenue, FY20: $111.11BNet income, FY20: $1.81BFY20Revenue, FY21: $125.98BNet income, FY21: $1.35BFY21Revenue, FY22: $144.55BNet income, FY22: $1.2BFY22Revenue, FY23: $154BNet income, FY23: $2.7BFY23Revenue, FY24: $163.07BNet income, FY24: $3.31BFY24Revenue, FY25: $194.78BNet income, FY25: −$6.67BFY25

Margins fiscal 2016–2025

  • Gross
  • Operating
  • Net
-10%0%10%20%7.3%-3.4%-3.9%FY16FY19FY22FY25

Latest quarter · Q3 FY2026 to 30 Sep 2026, filed 27 Oct 2026 · Full results →

Revenue
$50.65B+1.9% on a year
Gross margin
6.5%−0.2 pts on a year
Operating income
−$307.0M
Net income
−$71.00M
Diluted EPS
−$0.14
Free cash flow
−$3.86B−437% on a year

Comparable companies All of Health Care →

Centene Corporation beside the other S&P 500 members in Managed Health Care, then the largest in Health Care, by market value.

Centene Corporation and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
Centene CorporationCNC$37.04B+1.4%+96.9%+9.7%0.7%25.4
Elevance HealthELV$95.73B0.0%+31.2%+3.6%2.5%18.6
HumanaHUM$54.77B+1.4%+87.1%+22.0%0.8%44.0
UnitedHealth GroupUNH—+0.6%+20.2%———
Eli LillyLLY$1.37T+1.1%+41.8%+45.5%31.9%49.6
Johnson & JohnsonJNJ$686.1B+0.8%+47.0%+7.8%16.2%42.6
AbbVieABBV$525.9B+0.2%+26.5%+10.7%15.7%51.1

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Centene Corporation revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By segment

Centene Corporation revenue by segment, by fiscal year
RevenueFY 2022FY 2023FY 2024FY 2025
Medicaid$93.15B$100.8B+8.2%$101.4B+0.7%$110.4B+8.9%
Commercial$17.38B$24.84B+43.0%$33.70B+35.6%$42.00B+24.6%
Medicare$22.48B$22.26B−1.0%$23.03B+3.5%$37.21B+61.6%
Other$25.19B$16.73B−33.6%$16.88B+0.9%$16.85B−0.1%
Total revenue$144.5B$154.0B$163.1B$194.8B

Financial statements

Fiscal years, the latest ending 31 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Centene Corporation income statement, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$40.61B$48.38B$60.12B$74.64B$111.1B$126.0B$144.5B$154.0B$163.1B$194.8B
Revenue growth+78.4%+19.1%+24.3%+24.2%+48.9%+13.4%+14.7%+6.5%+5.9%+19.4%
Gross profit—————$14.49B$16.92B$17.64B$17.07B$14.21B
Operating income$1.26B$1.20B$1.46B$1.78B$3.08B$1.78B$1.32B$2.93B$3.17B−$7.62B
Net income$562.0M$828.0M$900.0M$1.32B$1.81B$1.35B$1.20B$2.70B$3.31B−$6.67B
Diluted EPS$1.71$2.34$2.26$3.14$3.12$2.28$2.07$4.95$6.31−$13.53
Gross margin—————11.5%11.7%11.5%10.5%7.3%
Operating margin3.1%2.5%2.4%2.4%2.8%1.4%0.9%1.9%1.9%−3.9%
Net margin1.4%1.7%1.5%1.8%1.6%1.1%0.8%1.8%2.0%−3.4%

Cash flow

Centene Corporation cash flow, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$1.85B$1.49B$1.23B$1.48B$5.50B$4.21B$6.26B$8.05B$154.0M$5.09B
Capital expenditure$306.0M$422.0M$675.0M$730.0M$869.0M$910.0M$1.00B$799.0M$644.0M$767.0M
Free cash flow$1.54B$1.07B$559.0M$753.0M$4.63B$3.29B$5.26B$7.25B−$490.0M$4.32B

Balance sheet and shares

Centene Corporation balance sheet and shares, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$3.93B$4.07B$5.34B$12.12B$10.80B$13.12B$12.07B$17.19B$14.06B$17.89B
Total debt$4.66B$4.70B$6.69B$14.51B$18.32B$22.66B$21.33B$18.88B$19.43B$18.16B
Shareholders' equity$5.89B$6.85B$10.92B$12.55B$25.77B$26.80B$24.06B$25.84B$26.41B$19.95B
Diluted shares328M353M399M420M579M591M582M546M524M493M

Quarterly figures

The last eight fiscal quarters, the latest ending 30 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Centene Corporation quarterly financial figures
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$40.80B$46.62B$48.74B$49.69B$49.73B$49.94B$53.58B$50.65B
Revenue, year on year+3.4%+15.4%+22.4%+18.2%+21.9%+7.1%+9.9%+1.9%
Gross margin9.3%11.3%6.2%6.7%5.1%11.3%8.6%6.5%
Operating income$175.0M$1.53B−$458.0M−$6.95B−$1.75B$1.86B$1.20B−$307.0M
Net income$283.0M$1.31B−$253.0M−$6.63B−$1.10B$1.54B$1.09B−$71.00M
Diluted EPS$0.56$2.63−$0.51−$13.50−$2.24$3.11$2.19−$0.14
Free cash flow−$741.0M$1.38B$1.58B$1.15B$224.0M$4.17B$3.42B−$3.86B

Operating KPIs

The operating figures Centene Corporation reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Centene Corporation operating KPIs
KPILatestPeriodChange on a yearRecent periods
Total at-risk membership25.7Mat 30 Sep 2026down 8.1%
Premium and service revenues$45.1Bquarter to 30 Sep 2026up 0.5%
Premium revenue$44.4Bquarter to 30 Sep 2026up 0.6%
Service revenue$735.0Mquarter to 30 Sep 2026down 4.8%
Medicaid revenue$29.6Bquarter to 30 Sep 2026up 5.8%
Medicare revenue$11.3Bquarter to 30 Sep 2026up 19.9%
Commercial revenue$8.7Bquarter to 30 Sep 2026down 20.9%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Centene Corporation's revenue in fiscal 2025?

$194.8 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), as reported in its annual report.

What was Centene Corporation's net income in fiscal 2025?

−$6.67 billion for fiscal year 2025 (the twelve months to 31 Dec 2025).

What were Centene Corporation's diluted earnings per share in fiscal 2025?

−$13.53 for fiscal year 2025 (the twelve months to 31 Dec 2025).

What is Centene Corporation's gross margin?

7.3% for fiscal year 2025 (the twelve months to 31 Dec 2025): gross profit divided by revenue.

What is Centene Corporation's operating margin?

−3.9% for fiscal year 2025 (the twelve months to 31 Dec 2025): operating income divided by revenue.

How much free cash flow did Centene Corporation generate in fiscal 2025?

$4.32 billion for fiscal year 2025 (the twelve months to 31 Dec 2025): operating cash flow less capital expenditure.

In the terminal

Twenty years of Centene Corporation's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans